Company introduction:
Venturepharm group is an Asia based, life science leader with principal activities in an most affordable world-class innovative full service plus model from venture capital, merchant banking, CRO, CMO, CSO, compound partnering to royalty sharing. Venturepharm engages in strategic licensing of therapeutic compound pipelines, and markets projects to China, an emerging global top five market. Two of the flagships from the group are public trade companies:
-Venturepharm Lab (HK stock exchange 8225), China's largest full-service CRO
- Commonwealth Biotechnologies, Inc (NASDAQ: Capital market “CBTE”),
The group now operates Eight distinct business units with over 4500 employees worldwide:
Company Details
- Employees
- 49
- Industry
- Medical Practices
- NAICS
-
Ambulatory Health Care ServicesOffices of Other Health PractitionersOutpatient Care CentersOther Ambulatory Health Care ServicesOffices of All Other Health PractitionersOutpatient Mental Health and Substance Abuse CentersAll Other Ambulatory Health Care ServicesOffices of PodiatristsBlood and Organ BanksAll Other Miscellaneous Ambulatory Health Care Services
- Website
- venturepharm.net
- Keywords
- plus model from venture capital.
Venturepharm Group Questions
Venturepharm Group's website is venturepharm.net
Venturepharm Group's LinkedIn profile is https://www.linkedin.com/company/venturepharm-group
Venturepharm Group has
49 employees.
View email and phone details for 49
employees at Venturepharm Group.
Venturepharm Group's industry is
Medical Practices
Venturepharm Group's top competitors are
Inhibitor Therapeutics, Inc.,
Inventiv Health Commercial,
Mundipharma,
Venturepharm Laboratories Limited.
Venturepharm Group's categories are Medical Practices
